pursue excellence of clinical research on chronic hepatitis b in china

Clicks: 117
ID: 233791
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #71 of 78 articles by views in lontar komputer

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In China universal vaccination program against hepatitis B virus (HBV) in newborns has led to a dramatic decline in HBsAg prevalence from 9.75% in 1992 to 7.18% in 2006. However, it is estimated that there are still around 90 million patients with chronic HBV infection, including 20-30 million with chronic hepatitis B (CHB). As recommended therapies, interferons and nucleos(t)ide analogues can effectively suppress HBV replication and thereby halt the progression of liver disease. Unfortunately, the current standard of care could not cure CHB in most cases. Developing direct antiviral agents targeting the specific steps of HBV life cycle or immunotherapy against the key steps of immune response to HBV infection will ultimately enable us to cure CHB. Chinese hepatologists have published more and more papers on HBV prevention and management, with the aim of optimizing current modalities and exploring new therapies. Adopting the public health policy to improve the accessibility and affordability of preventive and therapeutic drugs and increase the coverage of vaccination and standardized treatment is the most effective means to reduce the enormous health and socioeconomic burden of HBV-related diseases.
Reference Key
jidong2015linchuangpursue Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;JIA Jidong
Journal lontar komputer
Year 2015
DOI
10.3969/j.issn.1001-5256.2015.04.001
URL
Keywords
Gastroenterology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.